0 CHECKOUT

FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

  • ID: 1607904
  • April 2011
  • 5 pages
  • GlobalData

FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

Summary

Our report, “FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade” provides key update on the approval of Yervoy as the first targeted therapy for melanoma.

Scope

- Data and information on the FDA approval of Yervoy as the first targeted therapy for melanoma

Reasons to buy

- Develop understanding about the melanoma and how the approval of Yervoy will bring a paradigm shift in the treatment of melanoma.

Note: Product cover images may vary from those shown

1
1

2 Summary
3 Melanoma Overview
3.1 Disease Overview
3.2 Epidemiology
3.3 Diagnosis
4 Current Therapy Options
5 Unmet Need
6 Drivers and Barriers
6.1 Drivers
6.2 Barriers
7 Yervoy – New Second-Line Therapy for Advanced Metastatic Melanoma
7.1 020 Clinical Trial Details
7.2 Dosage and Pricing of Yervoy
8 Melanoma Market
9 Appendix
9.1 Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Expert Panel Validation
9.2 Contact Us
9.3 Disclaimer

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Photocure ASA
  • Roche Diagnostics Ltd.
  • Abbott Laboratories Ltd.
  • Pfizer, Inc.
  • Novartis AG
  • Becton, Dickinson and Company (BD)